When the macrophages’ ability to consume dying cancer cells or Upd3 production was decreased, tumor growth was significantly ...

STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced the appointment of accomplished cancer ...

Up to half of patients with Crohn's disease, an inflammatory bowel disease, develop a complication called fibrosis, where the ...

Molecular signals after severing an axolotl arm direct the remaining cells how to regrow the limb, offering potential ...

The complex tumor microenvironment (TME) in osteosarcoma is emerging as a critical factor in disease progression and treatment resistance. Recent insights highlight the intricate interplay between ...